237 related articles for article (PubMed ID: 26127034)
1. Quantification and comparison of visibility and image artifacts of a new liquid fiducial marker in a lung phantom for image-guided radiation therapy.
Scherman Rydhög J; Irming Jølck R; Andresen TL; Munck Af Rosenschöld P
Med Phys; 2015 Jun; 42(6):2818-26. PubMed ID: 26127034
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a novel liquid fiducial marker for multimodal image guidance in stereotactic body radiotherapy of prostate cancer.
De Roover R; Crijns W; Poels K; Peeters R; Draulans C; Haustermans K; Depuydt T
Med Phys; 2018 May; 45(5):2205-2217. PubMed ID: 29537613
[TBL] [Abstract][Full Text] [Related]
3. Novel artifact-robust and highly visible zinc solid fiducial marker for kilovoltage x-ray image-guided radiation therapy.
Wang T; Inubushi S; Ikeo N; Mukai T; Okumura K; Akasaka H; Yada R; Yoshida K; Miyawaki D; Ishihara T; Nakaoka A; Sasaki R
Med Phys; 2020 Oct; 47(10):4703-4710. PubMed ID: 32696571
[TBL] [Abstract][Full Text] [Related]
4. Visibility and artifacts of gold fiducial markers used for image guided radiation therapy of pancreatic cancer on MRI.
Gurney-Champion OJ; Lens E; van der Horst A; Houweling AC; Klaassen R; van Hooft JE; Stoker J; van Tienhoven G; Nederveen AJ; Bel A
Med Phys; 2015 May; 42(5):2638-47. PubMed ID: 25979055
[TBL] [Abstract][Full Text] [Related]
5. Quantification of MRI visibility and artifacts at 3T of liquid fiducial marker in a pancreas tissue-mimicking phantom.
Schneider S; Jølck RI; Troost EGC; Hoffmann AL
Med Phys; 2018 Jan; 45(1):37-47. PubMed ID: 29136287
[TBL] [Abstract][Full Text] [Related]
6. Qualitative evaluation of fiducial markers for radiotherapy imaging.
Chan MF; Cohen GN; Deasy JO
Technol Cancer Res Treat; 2015 Jun; 14(3):298-304. PubMed ID: 25230715
[TBL] [Abstract][Full Text] [Related]
7. Determination of optimal fiducial marker across image-guided radiation therapy (IGRT) modalities: visibility and artifact analysis of gold, carbon, and polymer fiducial markers.
Handsfield LL; Yue NJ; Zhou J; Chen T; Goyal S
J Appl Clin Med Phys; 2012 Sep; 13(5):3976. PubMed ID: 22955665
[TBL] [Abstract][Full Text] [Related]
8. Visibility of fiducial markers used for image-guided radiation therapy on optical coherence tomography for registration with CT: An esophageal phantom study.
Jelvehgaran P; Alderliesten T; Weda JJA; de Bruin M; Faber DJ; Hulshof MCCM; van Leeuwen TG; van Herk M; de Boer JF
Med Phys; 2017 Dec; 44(12):6570-6582. PubMed ID: 29023771
[TBL] [Abstract][Full Text] [Related]
9. Fiducial markers visibility and artefacts in prostate cancer radiotherapy multi-modality imaging.
Osman SOS; Russell E; King RB; Crowther K; Jain S; McGrath C; Hounsell AR; Prise KM; McGarry CK
Radiat Oncol; 2019 Dec; 14(1):237. PubMed ID: 31878967
[TBL] [Abstract][Full Text] [Related]
10. Improved image quality of cone beam CT scans for radiotherapy image guidance using fiber-interspaced antiscatter grid.
Stankovic U; van Herk M; Ploeger LS; Sonke JJ
Med Phys; 2014 Jun; 41(6):061910. PubMed ID: 24877821
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of different fiducial markers for image-guided radiotherapy and particle therapy.
Habermehl D; Henkner K; Ecker S; Jäkel O; Debus J; Combs SE
J Radiat Res; 2013 Jul; 54 Suppl 1(Suppl 1):i61-8. PubMed ID: 23824129
[TBL] [Abstract][Full Text] [Related]
12. Moving metal artifact reduction in cone-beam CT scans with implanted cylindrical gold markers.
Toftegaard J; Fledelius W; Seghers D; Huber M; Brehm M; Worm ES; Elstrøm UV; Poulsen PR
Med Phys; 2014 Dec; 41(12):121710. PubMed ID: 25471957
[TBL] [Abstract][Full Text] [Related]
13. Cervix Motion in 50 Cervical Cancer Patients Assessed by Daily Cone Beam Computed Tomographic Imaging of a New Type of Marker.
Langerak T; Mens JW; Quint S; Bondar L; Heijkoop S; Heijmen B; Hoogeman M
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):532-9. PubMed ID: 26460995
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Visibility and Artifacts of 11 Common Fiducial Markers for Image Guided Stereotactic Body Radiation Therapy in the Abdomen.
Slagowski JM; Colbert LE; Cazacu IM; Singh BS; Martin R; Koay EJ; Taniguchi CM; Koong AC; Bhutani MS; Herman JM; Beddar S
Pract Radiat Oncol; 2020; 10(6):434-442. PubMed ID: 31988039
[TBL] [Abstract][Full Text] [Related]
15. A Novel Liquid Fiducial Marker in Esophageal Cancer Image Guided Radiation Therapy: Technical Feasibility and Visibility on Imaging.
Machiels M; Voncken FEM; Jin P; van Dieren JM; Bartels-Rutten A; Alderliesten T; Aleman BMP; van Hooft JE; Hulshof MCCM
Pract Radiat Oncol; 2019 Nov; 9(6):e506-e515. PubMed ID: 31279938
[TBL] [Abstract][Full Text] [Related]
16. Preclinical investigation for developing injectable fiducial markers using a mixture of BaSO4 and biodegradable polymer for proton therapy.
Ahn SH; Gil MS; Lee DS; Han Y; Park HC; Sohn JW; Kim HY; Shin EH; Yu JI; Noh JM; Cho JS; Ahn SH; Choi DH
Med Phys; 2015 May; 42(5):2626-37. PubMed ID: 25979054
[TBL] [Abstract][Full Text] [Related]
17. Automated target tracking in kilovoltage images using dynamic templates of fiducial marker clusters.
Campbell WG; Miften M; Jones BL
Med Phys; 2017 Feb; 44(2):364-374. PubMed ID: 28035655
[TBL] [Abstract][Full Text] [Related]
18. Quantitative evaluation of image recognition performance of fiducial markers in real-time tumor-tracking radiation therapy.
Miyamoto N; Maeda K; Abo D; Morita R; Takao S; Matsuura T; Katoh N; Umegaki K; Shimizu S; Shirato H
Phys Med; 2019 Sep; 65():33-39. PubMed ID: 31430584
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of localization uncertainty of fiducial markers due to length and position variations induced by motion in CT imaging by measurement and modeling.
Ali I; Alsbou N; Oyewale S; Jaskowiak J; Ahmad S; Algan O
Gulf J Oncolog; 2016 May; 1(21):21-9. PubMed ID: 27250884
[TBL] [Abstract][Full Text] [Related]
20. Quantification of fiducial marker visibility for MRI-only prostate radiotherapy simulation.
Singhrao K; Ruan D; Fu J; Gao Y; Chee G; Yang Y; King C; Hu P; Kishan AU; Lewis JH
Phys Med Biol; 2020 Feb; 65(3):035015. PubMed ID: 31881546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
